Stay updated on Teriflunomide in Pediatric MS Clinical Trial
Sign up to get notified when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.

Latest updates to the Teriflunomide in Pediatric MS Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now renders a 403 Forbidden error with a Home link, replacing the full study record content and effectively removing the detailed trial information from view.SummaryDifference18%

- Check16 days agoChange DetectedThe page now shows a new revision tag: Revision: v3.7.0. It also removes several indexing/metadata entries (Multiple sclerosis, related topics:, MedlinePlus Genetics) along with the older Revision: v3.6.6, which suggests metadata cleanup rather than changes to substantive study information.SummaryDifference0.1%

- Check23 days agoChange DetectedTel Litwinsky, Israel, 52621 was added as a participating site. Qiryat Krinitzi, Israel, 52621 was removed from the list of study locations.SummaryDifference0.1%

- Check30 days agoChange DetectedA new site in Qiryat Krinitzi, Israel (52621) was added and the Tel Litwinsky site (52621) was removed, changing the study’s geographic footprint and potentially affecting participant access in Israel.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling a newer version of the page content.SummaryDifference0.0%

- Check59 days agoChange DetectedA new site revision label Revision: v3.6.5 was added, and several related topics links such as 'Multiple sclerosis' and 'MedlinePlus Genetics' were removed from the related topics section, indicating a small site navigation/content cleanup.SummaryDifference0.1%

Stay in the know with updates to Teriflunomide in Pediatric MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.